STTCOMP CDX FA LONG
Market Cap $33,604,817
Shares Issued 248,924,568
After 5 months in suspension CDX is trading again on Monday 26 February 2024.
CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. CONNEQT Pulse (Pulse), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Pulse is the only vital signs monitor targeted at home, clinician, and clinical trial use that provides measurements of both brachial blood pressure (the pressure at your arm) and central blood pressure (the pressure at your aorta/heart) in addition to multiple other vascular health biomarkers.
A wearable device with the SphygmoCor technology is soon to be launched
- Forums
- ASX - Short Term Trading
- STTrading weekend thread 24th and 25th of February 2024
STTCOMP CDX FA LONGMarket Cap $33,604,817Shares Issued...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online